BRIEF published on 04/28/2025 at 09:11, 7 months 6 days ago CEO Dr. Karsten Wildberger to Depart CECONOMY AG Leadership Transition Executive Change CECONOMY AG Friedrich Merz Karsten Wildberger
PRESS RELEASE published on 04/28/2025 at 09:06, 7 months 6 days ago EQS-Adhoc: CECONOMY AG: Withdrawal of CEO Dr. Karsten Wildberger CECONOMY AG CEO Dr. Karsten Wildberger resigns by mutual agreement to join Federal Republic of Germany's Cabinet as a Federal Minister Resignation CEO CECONOMY AG Karsten Wildberger Federal Minister
BRIEF published on 05/13/2024 at 06:39, 1 year 6 months ago CECONOMY AG Updates Financial Outlook for 2023/24 Sales Growth EBIT Forecast Financial Outlook CECONOMY AG 2023/24 Financial Year
PRESS RELEASE published on 05/13/2024 at 06:34, 1 year 6 months ago EQS-Adhoc: CECONOMY AG: CECONOMY specifies outlook for the business year 2023/24 CECONOMY AG specifies outlook for business year 2023/24, expecting adjusted EBIT of 290-310 million euros. Sales to increase across segments. Details to be released on May 15, 2024 Financial Results Sales Growth Adjusted EBIT Business Outlook CECONOMY AG
Published on 12/05/2025 at 02:35, 3 hours 40 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 15 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 10 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 15 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 45 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 24 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 50 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 15 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 30 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 31 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 14 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
